Authors
Loading...
Experimental study reveals that the Marburg I FSAP variant fails to inhibit arterial neointima formation in mice, indicating a molecular mechanism for heightened cardiovascular risk.
Sedding et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: